Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPG | P10696 | 2/20 | 0.62 |
| ▸ | ALPI | P09923 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28549268 | 0.84 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL29669994 | 0.84 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL11188512 | 0.83 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL1718560 | 0.83 | ALPG (0.62) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL5523502 | 0.83 | ALPG (0.62) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL11236967 | 0.82 | ALPG (0.58) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL7241260 | 0.82 | CYP19A1 (0.72) | ALPGALPITDP1PLAAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL409010 | 0.82 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL11362294 | 0.82 | CYP19A1 (0.65) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL1509735 | 0.82 | CYP19A1 (0.71) | ALPGALPITDP1PLAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050272936-A1 | Imidazolium cxcr3 inhibitors | SMITHKLINE BEECHAM CORPORATION | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272936-A1 | Imidazolium cxcr3 inhibitors | CXCR3, CXCR1, CCR7 | ALPG 4737/4885ALPI 3922/4885TDP1 4618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.